Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | XENE |
---|---|---|
09:32 ET | 2095 | 42.88 |
09:34 ET | 615 | 42.55 |
09:36 ET | 200 | 42.86 |
09:38 ET | 100 | 42.645 |
09:39 ET | 200 | 42.485 |
09:45 ET | 100 | 42.62 |
09:50 ET | 400 | 42.65 |
09:52 ET | 400 | 42.705 |
09:54 ET | 100 | 42.75 |
09:56 ET | 400 | 42.595 |
09:57 ET | 100 | 42.53 |
10:01 ET | 800 | 42.58 |
10:03 ET | 1600 | 42.625 |
10:08 ET | 2306 | 42.61 |
10:10 ET | 100 | 42.61 |
10:12 ET | 100 | 42.61 |
10:14 ET | 343 | 42.62 |
10:24 ET | 200 | 42.75 |
10:28 ET | 300 | 42.755 |
10:33 ET | 200 | 42.72 |
10:35 ET | 704 | 42.79 |
10:37 ET | 100 | 42.78 |
10:39 ET | 100 | 42.79 |
10:42 ET | 300 | 42.79 |
10:46 ET | 300 | 42.82 |
10:50 ET | 100 | 42.8 |
10:51 ET | 1402 | 42.955 |
10:53 ET | 4557 | 42.89 |
10:55 ET | 100 | 42.92 |
11:00 ET | 400 | 42.92 |
11:02 ET | 2976 | 42.84 |
11:04 ET | 1000 | 42.9 |
11:06 ET | 300 | 42.885 |
11:08 ET | 200 | 42.87 |
11:09 ET | 5023 | 42.97 |
11:11 ET | 100 | 42.95 |
11:15 ET | 100 | 42.975 |
11:29 ET | 100 | 42.995 |
11:31 ET | 1300 | 42.99 |
11:33 ET | 100 | 43.01 |
11:36 ET | 1800 | 42.58 |
11:38 ET | 1200 | 42.68 |
11:42 ET | 715 | 42.76 |
11:51 ET | 100 | 42.72 |
11:54 ET | 300 | 42.795 |
11:58 ET | 300 | 42.8 |
12:00 ET | 200 | 42.8 |
12:02 ET | 700 | 42.92 |
12:09 ET | 100 | 42.9 |
12:12 ET | 300 | 42.85 |
12:14 ET | 400 | 42.895 |
12:18 ET | 7984 | 43.125 |
12:20 ET | 1676 | 43.1 |
12:32 ET | 733 | 43.075 |
12:34 ET | 100 | 43.05 |
12:36 ET | 500 | 43.04 |
12:38 ET | 100 | 43.015 |
12:43 ET | 600 | 42.945 |
12:45 ET | 4190 | 43.02 |
12:48 ET | 680 | 42.97 |
12:50 ET | 200 | 42.96 |
12:52 ET | 100 | 42.97 |
12:54 ET | 104 | 42.96 |
12:56 ET | 200 | 42.965 |
12:57 ET | 200 | 42.95 |
01:01 ET | 322 | 42.89 |
01:03 ET | 905 | 42.92 |
01:06 ET | 100 | 42.915 |
01:08 ET | 500 | 42.96 |
01:14 ET | 200 | 42.97 |
01:15 ET | 400 | 42.985 |
01:19 ET | 100 | 42.99 |
01:21 ET | 501 | 42.95 |
01:24 ET | 1800 | 42.91 |
01:28 ET | 300 | 42.96 |
01:30 ET | 400 | 42.94 |
01:32 ET | 100 | 42.86 |
01:39 ET | 500 | 42.825 |
01:42 ET | 1100 | 42.78 |
01:44 ET | 700 | 42.835 |
01:50 ET | 100 | 42.845 |
01:51 ET | 625 | 42.83 |
01:55 ET | 200 | 42.83 |
01:57 ET | 1040 | 42.915 |
02:00 ET | 200 | 42.96 |
02:02 ET | 1800 | 43.055 |
02:06 ET | 300 | 43.04 |
02:08 ET | 1680 | 43.25 |
02:11 ET | 100 | 43.31 |
02:15 ET | 300 | 43.27 |
02:18 ET | 648 | 43.24 |
02:20 ET | 548 | 43.17 |
02:22 ET | 400 | 43.185 |
02:24 ET | 270 | 43.1574 |
02:26 ET | 1007 | 43.26 |
02:27 ET | 100 | 43.22 |
02:29 ET | 100 | 43.24 |
02:31 ET | 1100 | 43.32 |
02:33 ET | 300 | 43.3 |
02:36 ET | 400 | 43.37 |
02:38 ET | 9184 | 43.175 |
02:40 ET | 848 | 43.14 |
02:42 ET | 100 | 43.16 |
02:45 ET | 2180 | 43.14 |
02:47 ET | 100 | 43.1 |
02:49 ET | 1422 | 43.17 |
02:51 ET | 636 | 43.18 |
02:54 ET | 100 | 43.15 |
02:56 ET | 300 | 43.185 |
02:58 ET | 500 | 43.195 |
03:00 ET | 443 | 43.24 |
03:02 ET | 100 | 43.215 |
03:05 ET | 300 | 43.17 |
03:07 ET | 100 | 43.13 |
03:09 ET | 200 | 43.14 |
03:12 ET | 300 | 43.145 |
03:18 ET | 2100 | 43.085 |
03:20 ET | 200 | 43.05 |
03:21 ET | 809 | 43.08 |
03:23 ET | 525 | 43.05 |
03:25 ET | 339 | 43.005 |
03:27 ET | 610 | 43.04 |
03:30 ET | 240 | 43 |
03:32 ET | 800 | 42.995 |
03:34 ET | 2405 | 43.13 |
03:36 ET | 100 | 43.145 |
03:41 ET | 200 | 43.155 |
03:43 ET | 200 | 43.155 |
03:45 ET | 3619 | 43.05 |
03:48 ET | 700 | 42.93 |
03:50 ET | 1978 | 42.985 |
03:52 ET | 3529 | 43.1 |
03:54 ET | 4172 | 43.32 |
03:56 ET | 5673 | 43.08 |
03:57 ET | 7506 | 43.13 |
03:59 ET | 5864 | 43.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Xenon Pharmaceuticals Inc | 3.2B | -15.8x | --- |
MoonLake Immunotherapeutics | 3.2B | -65.9x | --- |
IDEAYA Biosciences Inc | 3.2B | -22.4x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Crinetics Pharmaceuticals Inc | 3.5B | -12.7x | --- |
Immunitybio Inc | 3.7B | -4.8x | --- |
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.15 |
EPS | $-2.73 |
Book Value | $12.31 |
P/E Ratio | -15.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.